Image: Clickup Wegovy is also semaglutide, but it is the version developed and registered specifically for chronic weight management
Nature 2001;411:805810
This means that people who take both drugs might not lose as much weight as those taking only semaglutide
This is the most common timing for UTI development during semaglutide treatment
Track these metrics weekly: Dose administered (mg, units, date, and time) Injection site (for rotation tracking) Side effects (type, severity 1 to 10, duration) Body weight (same time, same conditions each week) Body measurements (waist, hips, chest, if relevant) Appetite changes (subjective 1 to 10 scale) Energy levels (subjective 1 to 10 scale) Vial tracking (reconstitution date, volume remaining, expiration) This data tells you whether your dose is right, when to escalate, and whether the protocol is producing the desired outcomes